These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 35334088)
21. TGF-β1-activated kinase-1 regulates inflammation and fibrosis in the obstructed kidney. Ma FY; Tesch GH; Ozols E; Xie M; Schneider MD; Nikolic-Paterson DJ Am J Physiol Renal Physiol; 2011 Jun; 300(6):F1410-21. PubMed ID: 21367917 [TBL] [Abstract][Full Text] [Related]
22. Glomerular Injury Is Exacerbated in Lupus-Prone MRL/lpr Mice Treated with a Protease-Activated Receptor 2 Antagonist. Itto R; Oe Y; Imaruoka K; Sato E; Sekimoto A; Yamakage S; Kumakura S; Sato H; Ito S; Takahashi N Tohoku J Exp Med; 2019 Oct; 249(2):127-133. PubMed ID: 31666446 [TBL] [Abstract][Full Text] [Related]
23. Astragaloside IV from Astragalus membranaceus ameliorates renal interstitial fibrosis by inhibiting inflammation via TLR4/NF-кB in vivo and in vitro. Zhou X; Sun X; Gong X; Yang Y; Chen C; Shan G; Yao Q Int Immunopharmacol; 2017 Jan; 42():18-24. PubMed ID: 27855303 [TBL] [Abstract][Full Text] [Related]
24. PAR2 promotes M1 macrophage polarization and inflammation via FOXO1 pathway. Chen L; Gao B; Zhang Y; Lu H; Li X; Pan L; Yin L; Zhi X J Cell Biochem; 2019 Jun; 120(6):9799-9809. PubMed ID: 30552714 [TBL] [Abstract][Full Text] [Related]
26. Arctigenin suppresses renal interstitial fibrosis in a rat model of obstructive nephropathy. Li A; Zhang X; Shu M; Wu M; Wang J; Zhang J; Wang R; Li P; Wang Y Phytomedicine; 2017 Jul; 30():28-41. PubMed ID: 28545667 [TBL] [Abstract][Full Text] [Related]
27. Protease-activated receptor 2 induces ROS-mediated inflammation through Akt-mediated NF-κB and FoxO6 modulation during skin photoaging. Bang E; Kim DH; Chung HY Redox Biol; 2021 Aug; 44():102022. PubMed ID: 34082382 [TBL] [Abstract][Full Text] [Related]
28. MFAP4 deficiency alleviates renal fibrosis through inhibition of NF-κB and TGF-β/Smad signaling pathways. Pan Z; Yang K; Wang H; Xiao Y; Zhang M; Yu X; Xu T; Bai T; Zhu H FASEB J; 2020 Nov; 34(11):14250-14263. PubMed ID: 32905637 [TBL] [Abstract][Full Text] [Related]
29. Critical role of CXCL16 in hypertensive kidney injury and fibrosis. Xia Y; Entman ML; Wang Y Hypertension; 2013 Dec; 62(6):1129-37. PubMed ID: 24060897 [TBL] [Abstract][Full Text] [Related]
30. Hepatocyte growth factor ameliorates renal interstitial inflammation in rat remnant kidney by modulating tubular expression of macrophage chemoattractant protein-1 and RANTES. Gong R; Rifai A; Tolbert EM; Biswas P; Centracchio JN; Dworkin LD J Am Soc Nephrol; 2004 Nov; 15(11):2868-81. PubMed ID: 15504940 [TBL] [Abstract][Full Text] [Related]
31. Membrane rafts-redox signalling pathway contributes to renal fibrosis via modulation of the renal tubular epithelial-mesenchymal transition. Han WQ; Xu L; Tang XF; Chen WD; Wu YJ; Gao PJ J Physiol; 2018 Aug; 596(16):3603-3616. PubMed ID: 29863758 [TBL] [Abstract][Full Text] [Related]
32. Hematopoietic tissue factor-protease-activated receptor 2 signaling promotes hepatic inflammation and contributes to pathways of gluconeogenesis and steatosis in obese mice. Wang J; Chakrabarty S; Bui Q; Ruf W; Samad F Am J Pathol; 2015 Feb; 185(2):524-35. PubMed ID: 25476527 [TBL] [Abstract][Full Text] [Related]
33. The PAR-1 antagonist vorapaxar ameliorates kidney injury and tubulointerstitial fibrosis. Lok SWY; Yiu WH; Li H; Xue R; Zou Y; Li B; Chan KW; Chan LYY; Leung JCK; Lai KN; Tang SCW Clin Sci (Lond); 2020 Nov; 134(21):2873-2891. PubMed ID: 33078834 [TBL] [Abstract][Full Text] [Related]
34. Involvement of ERK1/2/NF-κB signal transduction pathway in TF/FVIIa/PAR2-induced proliferation and migration of colon cancer cell SW620. Guo D; Zhou H; Wu Y; Zhou F; Xu G; Wen H; Zhang X Tumour Biol; 2011 Oct; 32(5):921-30. PubMed ID: 21625939 [TBL] [Abstract][Full Text] [Related]
36. Bixin Confers Prevention against Ureteral Obstruction-Caused Renal Interstitial Fibrosis through Activation of the Nuclear Factor Erythroid-2-Related Factor2 Pathway in Mice. Li J; Yang Y; Wei S; Chen L; Xue L; Tian H; Tao S J Agric Food Chem; 2020 Aug; 68(31):8321-8329. PubMed ID: 32706966 [TBL] [Abstract][Full Text] [Related]
37. CXCR4 inhibition attenuates calcium oxalate crystal deposition-induced renal fibrosis. Ye Z; Xia Y; Zhou X; Li B; Yu W; Ruan Y; Li H; Ning J; Chen L; Rao T; Cheng F Int Immunopharmacol; 2022 Jun; 107():108677. PubMed ID: 35255299 [TBL] [Abstract][Full Text] [Related]
38. Peptide DR8 suppresses epithelial-to-mesenchymal transition via the TGF-β/MAPK signaling pathway in renal fibrosis. Deng B; Yang W; Wang D; Cheng L; Bu L; Rao J; Zhang J; Xie J; Zhang B Life Sci; 2020 Nov; 261():118465. PubMed ID: 32956665 [TBL] [Abstract][Full Text] [Related]
39. Quercetin inhibits kidney fibrosis and the epithelial to mesenchymal transition of the renal tubular system involving suppression of the Sonic Hedgehog signaling pathway. Liu X; Sun N; Mo N; Lu S; Song E; Ren C; Li Z Food Funct; 2019 Jun; 10(6):3782-3797. PubMed ID: 31180394 [TBL] [Abstract][Full Text] [Related]
40. Hydroxychloroquine alleviates renal interstitial fibrosis by inhibiting the PI3K/Akt signaling pathway. Li D; Yu K; Feng F; Zhang Y; Bai F; Zhang Y; Sun N; Fan J; Liu L; Yang H; Yang X Biochem Biophys Res Commun; 2022 Jun; 610():154-161. PubMed ID: 35462097 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]